References
- PauwelsRABuistASMaPJenkinsCRHurdSSCommitteeGSGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summaryRespir Care200146879882511463370
- BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 pt 1141814229603117
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- WedzichaJABestallJCGarrodRGarnhamRPaulEAJonesPWRandomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scaleEur Respir J19981223633699727786
- MahlerDARosielloRAHarverALentineTMcGovernJFDaubenspeckJAComparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway diseaseAm Rev Respir Dis19871356122912333592398
- VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
- van der MolenTWillemseBWSchokkerSten HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- HedenströmHMalmbergPAgarwalKReference values for lung function tests in female. Regression equations with smoking variablesBull Eur Physiopathol Respir1985215515574074961
- HedenströmHMalmbergPFridrikssonHVReference values for pulmonary function test in men: regression equations which include tobacco smoking variablesUpsala J Med Sci1986912993103811032
- American Thoracic Society; European Respiratory SocietyATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005Am J Respir Crit Care Med2005171891293015817806
- LangePCelliBAgustiALung-function trajectories leading to chronic obstructive pulmonary diseaseN Engl J Med2015373211112226154786
- HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
- SundhJJansonCJohanssonGCharacterization of secondary care for COPD in SwedenEur Clin Respir J201741127007928326177
- LisspersKJohanssonGJanssonCImprovement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS studyRespir Med201410891345135425002194
- SundhJMontgomerySHasselgrenMChange in health status in COPD: a seven-year follow-up cohort studyNPJ Prim Care Respir Med2016261607327763623
- WaatevikMSkorgeTDOmenaasEBakkePSGulsvikAJohannessenAIncreased prevalence of chronic obstructive pulmonary disease in a general populationRespir Med201310771037104523680166
- BischoffEWSchermerTRBorHBrownPvan WeelCvan den BoschWJTrends in COPD prevalence and exacerbation rates in Dutch primary careBr J Gen Pract20095956992793319891824
- StällbergBJansonCJohanssonGManagement, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)Prim Care Respir J2014231384524346825
- Di MarcoFVergaMReggenteMAnxiety and depression in COPD patients: the roles of gender and disease severityRespir Med2006100101767177416531031
- GudmundssonGGislasonTJansonCRisk factors for rehospitalisation in COPD: role of health status, anxiety and depressionEur Respir J200526341441916135721
- YohannesAMMulerovaHLavoieKThe association of depressive symptoms with rates of acute exacerbations in patients with COPD: results from a 3-year longitudinal follow-up of the ECLIPSE cohortJ Am Med Dir Assoc20171811955.e6959.e628733182
- EkerljungLMinchevaRHagstadSPrevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sampleJ Asthma Epub20177111910.1080/02770903
- AlshabanatAZafariZAlbanyanODairiMFitzGeraldJMAsthma and COPD overlap syndrome (ACOS): a systematic review and meta analysisPLoS One2015109e013606526336076
- WesterikJAMettingEIvan BovenJFTiersmaWKocksJWSchermerTRAssociations between chronic comorbidity and exacerbation risk in primary care patients with COPDRespir Res20171813128166777
- CouillardSLariveePCourteauJVanasseAEosinophils in COPD exacerbations are associated with increased readmissionsChest2017151236637327746201
- Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
- ZysmanMDesleeGCaillaudDRelationship between blood eosinophils, clinical characteristics, and mortality in patients with COPDInt J Chron Obstruct Pulmon Dis2017121819182428694695
- VelthoveKJBrackeMSouvereinPCIdentification of exacerbations in obstructive lung disease through biomarkersBiomarkers200914752352819863191
- MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
- HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247